Our world has been turned upside down. We have the daunting prospect of thousands, or even millions of people being affected by COVID-19. A lot of people have talked about a vaccine, and while a vaccine (which prevents you getting a disease) is vitally important, we have to look at what we can do when people do get the disease.
Despite politicised bad press, the malaria drug hydroxychloroquine has shown enormous promise in the treatment of COVID-19. That’s why The Palmer Foundation has made substantial resources available to fund clinical trials, scale up the availability of hydroxychloroquine, and have enough of the drug available for all Australians, free of charge.
The Palmer Foundation has supplied 30 million doses, which is with the Australian national medical stockpile.
It is important for us to see through the chaff out there. We hope you find these resources valuable. This is a situation that changes every day, and affects everyone. When it comes to life and death, politics and profit should not compete with real world solutions that are affordable to all right now.
The Attorney General provided a detailed, lengthy analysis to the Nebraska HHS lead, declaring that based on the available data, they “do not find clear and convincing evidence that a physician who first obtains informed consent and then utilizes ivermectin or hydroxychloroquine after COVID-19 violates UCA.”
In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.
And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.
Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”
